Home › Upcoming votes › Korsana Biosciences, Inc.
The deadline as the proxy statement states it: “Votes submitted by telephone must be received by 11:59 p.m. Eastern Time on November 12, 2026”. Shares held through a bank, a broker or a company plan can have a different deadline; the voting instruction form says.
Read the proxy statement on EDGAR
Ballot read from the proxy statement and checked. As listed in Korsana Biosciences, Inc.’s proxy statement, with the board’s recommendation on each item.
| # | Item | Proposed by | Board recommends | Last year (same kind of item) |
|---|---|---|---|---|
| 1 | Domestication Proposal (redomestication to the Cayman Islands) | Board | For | — |
| 2 | Continuation and Cayman Articles Proposal | Board | For | — |
| 3 | Adjournment Proposal Adjournment |
Board | For | — |
From Korsana Biosciences, Inc.’s Form 8-K, filed June 18, 2025, for the meeting held June 16, 2025 (read it on EDGAR). Support is the share of votes cast that were FOR: abstentions and broker non-votes are left out.
| Item | Support (of votes cast) | Reported outcome |
|---|---|---|
| Elect Director: Errol De Souza, Ph.D. | 95% | — |
| Elect Director: Regina Graul, Ph.D. | 96% | — |
| Elect Director: Peter M. Hecht, Ph.D. | 95% | — |
| Elect Director: Steven Hyman, M.D. | 95% | — |
| Elect Director: Michael Higgins | 95% | — |
| Elect Director: Dina Katabi, Ph.D. | 96% | — |
| 2. Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year e | 97% | — |
| 3. The compensation of the Company's named executive officers as disclosed in the Proxy Statement | 94% | Approved |
| 5. To approve a proposal to adjourn the Annual Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation | 96% | — |
The meeting facts and ballot come from the SEC proxy filings listed above. Ballots are read from the proxy statement and checked against the filing’s own text; when that check does not pass, the page shows “see the proxy statement” instead of a ballot. Last year’s figures are the company’s official Form 8-K results and the managers’ Form N-PX reports. Nothing on this page predicts how any shareholder will vote, and it is not investment advice. How this works.